← All companies
CLB
Core Laboratories Inc.
$10.71
+0.07 +0.66%
Key statistics
from XBRL data in SEC filingsMarket cap
$491M
Revenue (TTM)
$519M
Net income (TTM)
$24.4M
EPS (TTM)
$0.52
P/E ratio
20.6
Dividend yield
0.37%
Free cash flow
$25.8M
Cash
$22.7M
Total assets
$587M
Gross margin
—
52-week range
$9.72 – $20.36
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Jul 30, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Jul 29, 2026
8-K
Shareholder vote results
May 13, 2026
10-Q
Quarter ended 2026-03-31
May 1, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Apr 29, 2026
8-K
Regulation FD disclosure
Mar 23, 2026
10-K
Fiscal year ended 2025-12-31
Mar 23, 2026
8-K/A
Results of operations (earnings release)
Mar 17, 2026
8-K
Amended charter or bylaws
Mar 5, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 4, 2026
10-Q
Quarter ended 2025-09-30
Oct 23, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Oct 22, 2025
10-Q
Quarter ended 2025-06-30
Jul 25, 2025
8-K
Entered a material agreement; Results of operations (earnings release); Took on a direct financial obligation; Regulation FD disclosure
Jul 23, 2025
8-K
Shareholder vote results
May 27, 2025
10-Q
Quarter ended 2025-03-31
Apr 28, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Apr 23, 2025
10-K
Fiscal year ended 2024-12-31
Feb 13, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 29, 2025
10-Q
Quarter ended 2024-09-30
Oct 24, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Oct 23, 2024
10-Q
Quarter ended 2024-06-30
Jul 25, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Jul 24, 2024
8-K
Shareholder vote results
May 10, 2024
10-Q
Quarter ended 2024-03-31
Apr 25, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Apr 24, 2024
8-K
Director or officer change
Mar 25, 2024
10-K
Fiscal year ended 2023-12-31
Feb 15, 2024
8-K/A
Results of operations (earnings release)
Feb 15, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 31, 2024
10-Q
Quarter ended 2023-09-30
Nov 2, 2023
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 1, 2023
10-Q
Quarter ended 2023-06-30
Jul 27, 2023
8-K
Results of operations (earnings release); Regulation FD disclosure
Jul 26, 2023
8-K
Terminated a material agreement
Jul 18, 2023
8-K
Shareholder vote results
Jul 3, 2023
8-K
Entered a material agreement; Took on a direct financial obligation
May 5, 2023
Other filings
11-K
Jun 29, 2026
SCHEDULE 13G/A
May 15, 2026
SD
May 15, 2026